HI HB30 | 2022 | Regular Session
Note: Carry Over of previous HB30
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 21 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: House Health, Human Services, & Homelessness Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 21 2021 - 25% progression, died in committee
Action: 2021-12-10 - Carried over to 2022 Regular Session.
Pending: House Health, Human Services, & Homelessness Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires certain drug manufacturers to pay monetary penalties to the insurance commissioner for unsupported price increases on prescription drugs sold in the State. Provides for appeals and judicial review. Establishes the identified drug offset special fund. Requires annual reports to the legislature.
Title
Relating To Prescription Drugs.
Sponsors
| Rep. Roy Takumi [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-12-10 | Carried over to 2022 Regular Session. | |
| 2021-01-27 | House | Referred to HHH, CPC, FIN, referral sheet 1 |
| 2021-01-21 | House | Introduced and Pass First Reading. |
| 2021-01-20 | House | Pending introduction. |
Same As/Similar To
HB30 (Carry Over) 2021-01-27 - Referred to HHH, CPC, FIN, referral sheet 1
Subjects
Hawaii State Sources
| Type | Source |
|---|---|
| Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=30&year=2022 |
| Text | https://www.capitol.hawaii.gov/session2022/bills/HB30_.HTM |
